The lactose tolerance pill (LTP) is a pill that contains a synthetic version of the human lactase enzyme, which breaks down lactose into glucose, a solid that is then fermented into the sugars found in bread.
Unfortunately, the pill is not FDA-approved for use by people with lactose intolerances.
While some people have used LTPs to help manage their symptoms, it’s not a medically accepted treatment.
Now, thanks to a crowdfunding campaign, the LTP pill is making a comeback in the U.S. as a prescription medication.
LTP pills are often touted as a solution to lactose-related intolerance because they contain a synthetic lactase that is similar to human lactose.
They also have similar effects on the body, but are generally not FDA approved.
“This pill is designed to help patients tolerate the lactose that is in their food,” said Jennifer R. O’Neill, an associate professor of pharmacy at Northwestern University in Evanston, Ill.
“It doesn’t require a prescription and it doesn’t contain a medication that would require a doctor’s visit.”
LTP can also be used as a dietary supplement, and a small number of studies have found that using it can help reduce symptoms of irritable bowel syndrome, according to the campaign.
A LTP is a synthetic product that contains synthetic lactases that break down lactase-producing lactose, the primary form of lactose found in foods.
(Photo: J. Bryan Lowder, AP) The pill is sold as LTP Plus, a $10.99 pill that is sold under the brand name Nutricia, according of the campaign’s website.
The pill’s ingredients include synthetic lactate, which has a synthetic form of human lactate.
Nutricia says the product contains no lactose and is safe for people with LTS.
It also claims that the pill will not increase the risk of pancreatitis, a potentially life-threatening condition.
The campaign says that some LTS patients have had symptoms like bloating and diarrhea, but that these symptoms do not include symptoms like constipation or bloating that can be associated with lactase deficiency.
While the LTS pill is available over-the-counter, people should check with their healthcare provider to see if the pill could be beneficial for them.
A study in 2013 found that LTPPlus users reported a reduced risk of colon cancer than placebo users, and the U-M study also found that the LTB pills did not increase rates of pancreatic cancer in women.
The U-Mo study also included participants who had experienced lactose allergy symptoms, but did not report their symptoms.
The LTP campaign says the pill was approved in 2012 by the FDA for the treatment of lactase sensitivity, a disorder that is characterized by symptoms like diarrhea, bloating, abdominal pain and weight loss.
The company has raised more than $30,000 on Kickstarter, but is still waiting for a final review.
Oulson said that while the pill may not be medically approved, it is a viable alternative to prescription medications.
“A LTP plus pill is a good option for people who are trying to get better, but not necessarily for people in a chronic or debilitating condition,” O’Connor said.
“People can take a LTP in place of a prescription if they have a lactase problem, or a lactate intolerance pill is another option if they’re just having a difficult time making a lot of food.”
The LTP Pill campaign says it has been able to raise over $100,000 to continue production.
It will continue to raise money for future campaigns, including another $30k for a lactulose pill.
“To learn more about LTP, visit the campaign website.